Identification of Risk Factors for Initial Elevated Vancomyin Trough Concentrations.

Area of Science:

• Pharmacokinetics and Pharmacodynamics
• Clinical Pharmacy
• Nephrology

Background:

• Elevated vancomycin trough concentrations (>20 µg/mL) are linked to increased nephrotoxicity, mortality, and hospital stay.
• Understanding predictors of high vancomycin levels is crucial for patient safety.

Purpose of the Study:

• To identify variables predicting elevated initial vancomycin trough concentrations.
• To inform strategies for optimizing vancomycin dosing and minimizing adverse events.

Main Methods:

• Retrospective case-control study analyzing vancomycin trough concentrations from January 2013 to December 2014.
• Case patients (n=54) had initial trough >20 µg/mL; controls (n=140) had trough ≤20 µg/mL.
• Exclusion criteria included ICU stay, unstable renal function, and specific transplant/disease states.

Main Results:

• Multivariate analysis identified baseline serum creatinine, body mass index (BMI), heart failure, and malignancy as independent predictors of elevated vancomycin troughs.
• Reduced baseline renal function and higher BMI were significantly associated with increased risk.
• The presence of heart failure and/or malignancy further amplified this risk.

Conclusions:

• Baseline renal function and BMI are key factors in predicting elevated initial vancomycin trough concentrations.
• Co-existing heart failure and malignancy increase the risk of high vancomycin levels.
• Individualized dosing strategies should be considered for patients with these risk factors to achieve target concentrations.